Now Accepting Requests to Trial our Device at david_sheridan@promedixinc.com
1. Improve Emergency/Critical Care of Sepsis Resuscitation and Identification
2. Improve Home Patient Monitoring
1. Improve Emergency/Critical Care of Sepsis Resuscitation and Identification
2. Improve Home Patient Monitoring
CEO/President
Promedix has launched a propsective observational study in the ER. Patients will have capillary refill measurements with our device in triage and during their resuscitation. The primary objective is to evaluate the ability of our device to improve early sepsis detection. A peer-reviewed manuscript has been published and attached below
Promedix had an abstract selected for presentation at the highly competitive/peer-reviewed American Heart Association Resuscitation Science Symposium: November 14-16,2020
https://professional.heart.org/en/meetings/resuscitation-science-symposium
CTIP, Consortium for Technology and Innovation in Pediatrics, an FDA pediatric device consoritum received over 90 applications to their grant competition. Promedix was selected as a winner and it's ability to improve pediatric sepsis care
Promedix launched a clinical trial in the adult ICU and inpatient floors to validate their technology in sepsis resuscitation
Promedix presented research findings at the highly competitive Pediatric Academic Society national meeting
Promedix received an investment from Ideaship LLC to strategically develop their patent portfolio strategy. Ideaship serves as a trusted advisor as well.
Promedix was an awardee of the highly competitive $100,000 Business Oregon Innovation Grant.
https://www.oregon4biz.com/About-Us/Investments-Report/Quarterly-Reports/Q4.php
Sepsis and Patient Decompensation
Growing evidence of literature around the use of our technology with references included
Copyright © 2020 Promedixinc - All Rights Reserved.
Powered by GoDaddy
